Search Results - "BADGWELL, Donna"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Development of a Multimarker Assay for Early Detection of Ovarian Cancer by YURKOVETSKY, Zoya, SKATES, Steven, MENON, Usha, LU, Karen, BADGWELL, Donna, BAST, Robert C, LOKSHIN, Anna E, LOMAKIN, Aleksey, NOLEN, Brian, PULSIPHER, Trenton, MODUGNO, Francesmary, MARKS, Jeffrey, GODWIN, Andrew, GORELIK, Elieser, JACOBS, Ian

    Published in Journal of clinical oncology (01-05-2010)
    “…Early detection of ovarian cancer has great promise to improve clinical outcome. Ninety-six serum biomarkers were analyzed in sera from healthy women and from…”
    Get full text
    Journal Article
  2. 2

    Early detection of ovarian cancer by Badgwell, Donna, Bast, Jr, Robert C

    Published in Disease markers (2007)
    “…Despite advances in therapy, ovarian cancer remains the most deadly of the gynecological cancers. Less than 30% of women with advanced stage disease survive…”
    Get full text
    Journal Article
  3. 3

    Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer by Simmons, Archana R, Clarke, Charlotte H, Badgwell, Donna B, Lu, Zhen, Sokoll, Lori J, Lu, Karen H, Zhang, Zhen, Bast, Jr, Robert C, Skates, Steven J

    “…Longitudinal multimarker combinations have the potential to improve sensitivity while maintaining the high specificity required for the early detection of…”
    Get more information
    Journal Article
  4. 4

    Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer by Clarke, Charlotte H, Yip, Christine, Badgwell, Donna, Fung, Eric T, Coombes, Kevin R, Zhang, Zhen, Lu, Karen H, Bast, Robert C

    Published in Gynecologic oncology (01-09-2011)
    “…Abstract Objective The low prevalence of ovarian cancer demands both high sensitivity (> 75%) and specificity (99.6%) to achieve a positive predictive value of…”
    Get full text
    Journal Article
  5. 5

    IL-6 signaling via the STAT3/SOCS3 pathway: Functional Analysis of the Conserved STAT3 N-domain by Zhang, Ling, Badgwell, Donna B, Bevers, Jack J. III, Schlessinger, Karni, Murray, Peter J, Levy, David E, Watowich, Stephanie S

    Published in Molecular and cellular biochemistry (01-08-2006)
    “…The conserved N-domain of the STAT proteins has been implicated in several activities crucial to cytokine signaling including receptor recruitment and STAT…”
    Get full text
    Journal Article
  6. 6

    Ethanol and aloe emodin alter the p53 mutational spectrum in ultraviolet radiation-induced murine skin tumors by Badgwell, Donna B., Walker, Christopher M., Baker, Whitney T., Strickland, Faith M.

    Published in Molecular carcinogenesis (01-03-2004)
    “…Mutations in the p53 tumor‐suppressor gene contribute to the development of skin cancer, and the spectrum of mutations in this gene correlates with specific…”
    Get full text
    Journal Article
  7. 7

    Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus by Moore, Richard G, Brown, Amy K, Miller, M. Craig, Badgwell, Donna, Lu, Zhen, Allard, W. Jeffrey, Granai, C.O, Bast, Robert C, Lu, Karen

    Published in Gynecologic oncology (01-08-2008)
    “…Abstract Objective Tumor markers with increased sensitivity and specificity for endometrial cancer are needed to help monitor response to therapy and to detect…”
    Get full text
    Journal Article
  8. 8

    The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways by Badgwell, D B, Lu, Z, Le, K, Gao, F, Yang, M, Suh, G K, Bao, J-J, Das, P, Andreeff, M, Chen, W, Yu, Y, Ahmed, A A, S-L Liao, W, Bast, R C

    Published in Oncogene (05-01-2012)
    “…Ovarian cancers migrate and metastasize over the surface of the peritoneal cavity. Consequently, dysregulation of mechanisms that limit cell migration may be…”
    Get full text
    Journal Article
  9. 9

    Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment by Badgwell, Donna, Lu, Zhen, Cole, Laurence, Fritsche, Herbert, Atkinson, Edward N, Somers, Elizabeth, Allard, Jeffrey, Moore, Richard G, Lu, Karen H, Bast, Robert C

    Published in Gynecologic oncology (01-09-2007)
    “…Abstract Objectives. Early detection of ovarian cancer should improve overall survival. Multiple serum markers have been evaluated as possible tests to detect…”
    Get full text
    Journal Article
  10. 10

    Urinary levels of Bcl-2 are elevated in ovarian cancer patients by Anderson, Nicole S, Bermudez, Yira, Badgwell, Donna, Chen, Ren, Nicosia, Santo V, Bast, Robert C, Kruk, Patricia A

    Published in Gynecologic oncology (01-01-2009)
    “…Abstract Objective(s) The poor prognosis associated with ovarian cancer is due to the lack of overt early symptoms and the absence of reliable diagnostic…”
    Get full text
    Journal Article
  11. 11

    Prevention and early detection of ovarian cancer: mission impossible? by Bast, Jr, Robert C, Brewer, Molly, Zou, Changping, Hernandez, Mary A, Daley, Mary, Ozols, Robert, Lu, Karen, Lu, Zhen, Badgwell, Donna, Mills, Gordon B, Skates, Steven, Zhang, Zhen, Chan, Dan, Lokshin, Anna, Yu, Yinhua

    Published in Recent results in cancer research (2007)
    “…Epithelial ovarian cancer is neither a common nor a rare disease. In the United States, the prevalence of ovarian cancer in postmenopausal women (1 in 2,500)…”
    Get more information
    Journal Article
  12. 12

    Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers by Yu, Yinhua, Luo, Robert, Lu, Zhen, Wei Feng, Wei, Badgwell, Donna, Issa, Jean-Pierre, Rosen, Daniel G, Liu, Jinsong, Bast, Jr, Robert C

    Published in Methods in enzymology (2006)
    “…ARHI is a maternally imprinted tumor suppressor gene that is downregulated in 60% of ovarian and breast cancers. Loss of ARHI expression is associated with…”
    Get more information
    Journal Article
  13. 13

    The role of the conserved N -terminal domain of STAT3 in STAT3 dephosphorylation and nuclear export by Badgwell, Donna Beard

    Published 01-01-2004
    “…Rapid redistribution of STAT subcellular localization is an essential feature of cytokine signaling. To elucidate the molecular basis of STAT3 function, which…”
    Get full text
    Dissertation